ANCA-Associated Vasculitis

被引:1
作者
Sharma, Purva [1 ]
Zonozi, Reza [2 ,3 ]
Geetha, Duvuru [4 ]
机构
[1] Northwell Hlth, Glomerular Ctr, Div Kidney Dis & Hypertens, Great Neck, NY USA
[2] Nephrol Associates Northern Virginia, Fairfax, VA USA
[3] Inova Fairfax Hosp, Falls Church, VA USA
[4] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA
来源
ADVANCES IN KIDNEY DISEASE AND HEALTH | 2024年 / 31卷 / 03期
关键词
ANCA; Rituximab; Plasmapheresis; Vasculitis; ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY CLASSIFICATION CRITERIA; 2022; AMERICAN-COLLEGE; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; DAILY ORAL CYCLOPHOSPHAMIDE; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; RENAL SURVIVAL; CRESCENTIC GLOMERULONEPHRITIS; WEGENERS-GRANULOMATOSIS;
D O I
10.1053/j.akdh.2024.04.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts. AAV tends to present in characteristic phenotypes categorized clinically as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA). Kidney involvement is a common feature of AAV, and has important implications on disease prognosis and management. Existing therapies have been refined and improvements in our understanding of the pathophysiology of AAV has led to approval of novel therapies. In this review, we provide an overview of epidemiology, disease mechanisms, clinical presentation and review therapeutic strategies for induction and maintenance of remission.
引用
收藏
页码:194 / 205
页数:12
相关论文
共 97 条
[31]   Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis [J].
Gulati, Kavita ;
Edwards, Helena ;
Prendecki, Maria ;
Cairns, Thomas D. ;
Condon, Marie ;
Galliford, Jack ;
Griffith, Megan ;
Levy, Jeremy B. ;
Tam, Frederick W. K. ;
Tanna, Anisha ;
Pusey, Charles D. ;
McAdoo, Stephen P. .
KIDNEY INTERNATIONAL, 2021, 100 (06) :1316-1324
[32]   Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases [J].
Haas, M ;
Eustace, JA .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2145-2152
[33]   Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up [J].
Harper, Lorraine ;
Morgan, Matthew D. ;
Walsh, Michael ;
Hoglund, Peter ;
Westman, Kerstin ;
Flossmann, Oliver ;
Tesar, Vladimir ;
Vanhille, Phillipe ;
de Groot, Kirsten ;
Luqmani, Raashid ;
Felipe Flores-Suarez, Luis ;
Watts, Richard ;
Pusey, Charles ;
Bruchfeld, Annette ;
Rasmussen, Niels ;
Blockmans, Daniel ;
Savage, Caroline O. ;
Jayne, David .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :955-960
[34]   Determinants of outcome in ANCA-associated glomerulonephritis:: A prospective clinico-histopathological analysis of 96 patients [J].
Hauer, HA ;
Bajema, IM ;
Van Houwelingen, HC ;
Ferrario, F ;
Noël, LH ;
Waldherr, R ;
Jayne, DRW ;
Rasmussen, N ;
Bruijn, JA ;
Hagen, EC .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1732-1742
[35]   Renal histology in ANCA-associated vasculitis:: Differences between diagnostic and serologic subgroups [J].
Hauer, HA ;
Bajema, IM ;
van Houwelingen, HC ;
Ferrario, F ;
Noël, LH ;
Waldherr, R ;
Jayne, DRW ;
Rasmussen, N ;
Bruijn, JA ;
Hagen, EC .
KIDNEY INTERNATIONAL, 2002, 61 (01) :80-89
[36]   Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Controlled Trial [J].
Hiemstra, Thomas F. ;
Walsh, Michael ;
Mahr, Alfred ;
Savage, Caroline O. ;
de Groot, Kirsten ;
Harper, Lorraine ;
Hauser, Thomas ;
Neumann, Irmgard ;
Tesar, Vladimir ;
Wissing, Karl-Martin ;
Pagnoux, Christian ;
Schmitt, Wilhelm ;
Jayne, David R. W. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (21) :2381-2388
[37]   WEGENER GRANULOMATOSIS - AN ANALYSIS OF 158 PATIENTS [J].
HOFFMAN, GS ;
KERR, GS ;
LEAVITT, RY ;
HALLAHAN, CW ;
LEBOVICS, RS ;
TRAVIS, WD ;
ROTTEM, M ;
FAUCI, AS .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) :488-498
[38]   Predictors of relapse and treatment resistance in antineutrophil cytoplasmic anti body-associated small-vessel vasculitis [J].
Hogan, SL ;
Falk, RJ ;
Chin, H ;
Cai, JW ;
Jennette, CE ;
Jennette, JC ;
Nachman, PH .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (09) :621-631
[39]   ANCA vasculitis in the elderly [J].
Hoganson, Deana D. ;
From, Aaron M. ;
Michel, Clement J., Jr. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (02) :78-81
[40]   A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies [J].
Jayne, D ;
Rasmussen, N ;
Andrassy, K ;
Bacon, P ;
Tervaert, JWC ;
Dadoniene, J ;
Ekstrand, A ;
Gaskin, G ;
Gregorini, G ;
de Groot, K ;
Gross, W ;
Hagen, EC ;
Mirapeix, E ;
Pettersson, E ;
Siegert, C ;
Sinico, A ;
Tesar, V ;
Westman, K ;
Pusey, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) :36-44